Studies also demonstrated that PD-1 expression increased in samples from patients with HNSCC compared with normal oral mucosa samples [33], suggesting that PD-1 blockade should actually be more effective in enhancing the antitumor immune response in HNSCC. Here, PDCD1 is linked to head and neck squamous cell carcinoma.